Stories

Photo gallery: In Thailand, investigating a lifechanging gonorrhoea treatment

There are 376 million new cases of curable STIs across the world every year. Antibiotic resistance is making them harder and sometimes impossible to treat. The bacteria that causes gonorrhoea is particularly prone to drug resistance. To address this health challenge, GARDP is working on a new antibiotic, zoliflodacin, for the treatment of gonorrhoea. The treatment is currently being evaluated in a global phase 3 trial. One of the countries where the treatment is being evaluated is Thailand.